28094445|t|Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons
28094445|a|The transient receptor potential vanilloid type 1 (TRPV1) receptor is a polymodal molecular integrator in the pain pathway expressed in Aδ - and C-fibre nociceptors and is responsible for the thermal hyperalgesia associated with inflammatory pain. Noradrenaline strongly inhibited the activity of TRPV1 channels in dorsal root ganglia neurons. The effect of noradrenaline was reproduced by clonidine and antagonized by yohimbine, consistent with contribution of α2 adrenergic receptors. The inhibitory effect of noradrenaline on TRPV1 channels was dependent on calcium influx and linked to calcium/calmodulin-dependent protein kinase II. In spinal cord slices, clonidine reduced the frequency of capsaicin - induced miniature EPSCs in the presence of tetrodotoxin and ω-conotoxin-MVIIC, consistent with inhibition of presynaptic TRPV1 channels by α2 adrenergic receptors. We suggest that modulation of presynaptic TRPV1 channels in nociceptive neurons by descending noradrenergic inputs may constitute a mechanism for noradrenaline to modulate incoming noxious stimuli in the dorsal horn of the spinal cord. The transient receptor potential vanilloid type 1 (TRPV1) receptor is a well-known contributor to nociceptor excitability. To address whether noradrenaline can down-regulate TRPV1 channel activity in nociceptors and reduce their synaptic transmission, the effects of noradrenaline and clonidine were tested on the capsaicin - activated current recorded from acutely dissociated small diameter (<27 μm) dorsal root ganglia (DRG) neurons and on miniature (m)EPSCs recorded from large lamina I neurons in horizontal spinal cord slices. Noradrenaline or clonidine inhibited the capsaicin - activated current by ∼60%, and the effect was reversed by yohimbine, confirming that it was mediated by activation of α2 adrenergic receptors. Similarly, clonidine reduced the frequency of capsaicin - induced mEPSCs by ∼60%. Inhibition of capsaicin - activated current by noradrenaline was mediated by GTP binding proteins, and was highly dependent on calcium influx. The inhibitory effect of noradrenaline on the capsaicin - activated current was not affected either by blocking the activity of protein kinase A with H89, or by blocking the activity of protein kinase C with bisindolylmaleimide II. In contrast, when the calcium/calmodulin-dependent protein kinase II (CaMKII) was blocked with KN-93, the inhibitory effect of noradrenaline on the capsaicin - activated current was greatly reduced, suggesting that activation of adrenergic receptors in DRG neurons is preferentially linked to CaMKII activity. We suggest that modulation of TRPV1 channels by noradrenaline in nociceptive neurons is a mechanism whereby noradrenaline may suppress incoming noxious stimuli at the primary synaptic afferents in the dorsal horn of the spinal cord.
28094445	0	11	Presynaptic	T026	C0206181
28094445	12	22	inhibition	T052	C3463820
28094445	26	89	transient receptor potential vanilloid type 1 (TRPV1) receptors	T116,T192	C1564816
28094445	93	106	noradrenaline	T109,T121,T125	C0028351
28094445	110	129	nociceptive neurons	T023	C0028246
28094445	134	196	transient receptor potential vanilloid type 1 (TRPV1) receptor	T116,T192	C1564816
28094445	240	252	pain pathway	T044	C1518855
28094445	253	262	expressed	T045	C1171362
28094445	266	268	Aδ	T026	C0027750
28094445	275	282	C-fibre	T023	C0006549
28094445	283	294	nociceptors	T023	C0028246
28094445	322	342	thermal hyperalgesia	T184	C0751214
28094445	343	358	associated with	T080	C0332281
28094445	359	376	inflammatory pain	T184	C0234251
28094445	378	391	Noradrenaline	T109,T121,T125	C0028351
28094445	401	410	inhibited	T080	C0311403
28094445	415	423	activity	T052	C0441655
28094445	427	441	TRPV1 channels	T116,T123	C1563722
28094445	445	464	dorsal root ganglia	T023	C0017070
28094445	465	472	neurons	T025	C0027882
28094445	478	484	effect	T080	C1280500
28094445	488	501	noradrenaline	T109,T121,T125	C0028351
28094445	520	529	clonidine	T109,T121	C0009014
28094445	534	545	antagonized	T120	C0243076
28094445	549	558	yohimbine	T109,T121	C0724441
28094445	592	615	α2 adrenergic receptors	T116,T192	C0001639
28094445	621	631	inhibitory	T044	C0521849
28094445	632	638	effect	T080	C1280500
28094445	642	655	noradrenaline	T109,T121,T125	C0028351
28094445	659	673	TRPV1 channels	T116,T123	C1563722
28094445	691	705	calcium influx	T043	C2610217
28094445	720	766	calcium/calmodulin-dependent protein kinase II	T116,T126	C0769224
28094445	771	782	spinal cord	T023	C0037925
28094445	783	789	slices	T167	C1519355
28094445	791	800	clonidine	T109,T121	C0009014
28094445	801	808	reduced	T080	C0392756
28094445	826	835	capsaicin	T109,T121	C0006931
28094445	838	845	induced	T169	C0205263
28094445	846	861	miniature EPSCs	T042	C2350764
28094445	881	893	tetrodotoxin	T109,T123,T131	C0039705
28094445	898	915	ω-conotoxin-MVIIC	T116,T121	C0170672
28094445	933	943	inhibition	T052	C3463820
28094445	947	958	presynaptic	T026	C0206181
28094445	959	973	TRPV1 channels	T116,T123	C1563722
28094445	977	1000	α2 adrenergic receptors	T116,T192	C0001639
28094445	1018	1028	modulation	UnknownType	C0678672
28094445	1032	1043	presynaptic	T026	C0206181
28094445	1044	1058	TRPV1 channels	T116,T123	C1563722
28094445	1062	1081	nociceptive neurons	T023	C0028246
28094445	1096	1109	noradrenergic	T044	C0599861
28094445	1110	1116	inputs	T077	C1708517
28094445	1148	1161	noradrenaline	T109,T121,T125	C0028351
28094445	1165	1173	modulate	UnknownType	C0678672
28094445	1183	1198	noxious stimuli	T067	C0234402
28094445	1206	1236	dorsal horn of the spinal cord	T023	C0228575
28094445	1242	1304	transient receptor potential vanilloid type 1 (TRPV1) receptor	T116,T192	C1564816
28094445	1336	1346	nociceptor	T023	C0028246
28094445	1347	1359	excitability	T184	C0235169
28094445	1380	1393	noradrenaline	T109,T121,T125	C0028351
28094445	1398	1411	down-regulate	T044	C0013081
28094445	1412	1425	TRPV1 channel	T116,T123	C1563722
28094445	1426	1434	activity	T052	C0441655
28094445	1438	1449	nociceptors	T023	C0028246
28094445	1454	1460	reduce	T080	C0392756
28094445	1467	1488	synaptic transmission	T043	C0027793
28094445	1494	1501	effects	T080	C1280500
28094445	1505	1518	noradrenaline	T109,T121,T125	C0028351
28094445	1523	1532	clonidine	T109,T121	C0009014
28094445	1552	1561	capsaicin	T109,T121	C0006931
28094445	1564	1573	activated	T052	C1879547
28094445	1574	1581	current	T042	C2350764
28094445	1596	1603	acutely	T079	C0205178
28094445	1640	1659	dorsal root ganglia	T023	C0017070
28094445	1661	1664	DRG	T023	C0017070
28094445	1666	1673	neurons	T025	C0027882
28094445	1681	1699	miniature (m)EPSCs	T042	C2350764
28094445	1720	1728	lamina I	T024	C1709063
28094445	1729	1736	neurons	T025	C0027882
28094445	1740	1750	horizontal	T082	C0205126
28094445	1751	1762	spinal cord	T023	C0037925
28094445	1763	1769	slices	T167	C1519355
28094445	1771	1784	Noradrenaline	T109,T121,T125	C0028351
28094445	1788	1797	clonidine	T109,T121	C0009014
28094445	1812	1821	capsaicin	T109,T121	C0006931
28094445	1824	1833	activated	T052	C1879547
28094445	1834	1841	current	T042	C2350764
28094445	1859	1865	effect	T080	C1280500
28094445	1882	1891	yohimbine	T109,T121	C0724441
28094445	1928	1938	activation	T052	C1879547
28094445	1942	1965	α2 adrenergic receptors	T116,T192	C0001639
28094445	1978	1987	clonidine	T109,T121	C0009014
28094445	1988	1995	reduced	T080	C0392756
28094445	2013	2022	capsaicin	T109,T121	C0006931
28094445	2025	2032	induced	T169	C0205263
28094445	2033	2039	mEPSCs	T042	C2350764
28094445	2049	2059	Inhibition	T052	C3463820
28094445	2063	2072	capsaicin	T109,T121	C0006931
28094445	2075	2084	activated	T052	C1879547
28094445	2085	2092	current	T042	C2350764
28094445	2096	2109	noradrenaline	T109,T121,T125	C0028351
28094445	2126	2146	GTP binding proteins	T116,T126	C0086376
28094445	2176	2190	calcium influx	T043	C3158761
28094445	2196	2206	inhibitory	T044	C0521849
28094445	2207	2213	effect	T080	C1280500
28094445	2217	2230	noradrenaline	T109,T121,T125	C0028351
28094445	2238	2247	capsaicin	T109,T121	C0006931
28094445	2250	2259	activated	T052	C1879547
28094445	2260	2267	current	T042	C2350764
28094445	2295	2303	blocking	T169	C0332206
28094445	2308	2316	activity	T052	C0441655
28094445	2320	2336	protein kinase A	T116,T126	C1259877
28094445	2342	2345	H89	T109,T121	C0082782
28094445	2353	2361	blocking	T169	C0332206
28094445	2366	2374	activity	T052	C0441655
28094445	2378	2394	protein kinase C	T116,T126	C0033634
28094445	2400	2422	bisindolylmaleimide II	T109,T121	C0761057
28094445	2446	2492	calcium/calmodulin-dependent protein kinase II	T116,T126	C0769224
28094445	2494	2500	CaMKII	T116,T126	C0248868
28094445	2506	2513	blocked	T169	C0332206
28094445	2519	2524	KN-93	T109	C0124673
28094445	2530	2540	inhibitory	T044	C0521849
28094445	2541	2547	effect	T080	C1280500
28094445	2551	2564	noradrenaline	T109,T121,T125	C0028351
28094445	2572	2581	capsaicin	T109,T121	C0006931
28094445	2584	2593	activated	T052	C1879547
28094445	2594	2601	current	T042	C2350764
28094445	2614	2621	reduced	T080	C0392756
28094445	2639	2649	activation	T052	C1879547
28094445	2653	2673	adrenergic receptors	T116,T192	C0034783
28094445	2677	2680	DRG	T023	C0017070
28094445	2681	2688	neurons	T025	C0027882
28094445	2717	2723	CaMKII	T116,T126	C0248868
28094445	2724	2732	activity	T052	C0441655
28094445	2750	2760	modulation	UnknownType	C0678672
28094445	2764	2778	TRPV1 channels	T116,T123	C1563722
28094445	2782	2795	noradrenaline	T109,T121,T125	C0028351
28094445	2799	2818	nociceptive neurons	T023	C0028246
28094445	2842	2855	noradrenaline	T109,T121,T125	C0028351
28094445	2878	2893	noxious stimuli	T067	C0234402
28094445	2909	2917	synaptic	T030	C0039062
28094445	2918	2927	afferents	T025	C0027883
28094445	2935	2965	dorsal horn of the spinal cord	T023	C0228575